On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors

Lori I. Robins, Seth M. Dixon, David K. Wilson, Mark J. Kurth

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aldose reductase (AKR1B1; ALR2; E.C. 1.1.1.21) is an NADPH-dependent carbonyl reductase which has long been associated with complications resulting from the elevated blood glucose often found in diabetics. The development of effective inhibitors has been plagued by lack of specificity which has led to side effects in clinical trials. To address this problem, a library of bead-immobilized compounds was screened against fluorescently labeled aldose reductase in the presence of fluorescently labeled aldehyde reductase, a non-target enzyme, to identify compounds which were aldose reductase specific. Picked beads were decoded via novel bifunctional bead mass spec-based techniques and kinetic analysis of the ten inhibitors which were identified using this protocol yielded IC50 values in the micromolar range. Most importantly, all of these compounds showed a preference for aldose reductase with selectivities as high as ∼7500-fold. The most potent of these exhibited uncompetitive inhibition versus the carbonyl-containing substrate d/l-glyceraldehyde with a Ki of 1.16 μM.

Original languageEnglish (US)
Pages (from-to)7728-7735
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume14
Issue number23
DOIs
StatePublished - Dec 1 2006

Fingerprint

Aldehyde Reductase
Glyceraldehyde
Inhibitory Concentration 50
Libraries
Blood Glucose
Clinical Trials
Kinetics
Substrates
Enzymes

Keywords

  • Aldose reductase
  • Diabetes
  • Inhibitors
  • Selective on-bead assay

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors. / Robins, Lori I.; Dixon, Seth M.; Wilson, David K.; Kurth, Mark J.

In: Bioorganic and Medicinal Chemistry, Vol. 14, No. 23, 01.12.2006, p. 7728-7735.

Research output: Contribution to journalArticle

Robins, Lori I. ; Dixon, Seth M. ; Wilson, David K. ; Kurth, Mark J. / On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors. In: Bioorganic and Medicinal Chemistry. 2006 ; Vol. 14, No. 23. pp. 7728-7735.
@article{b2c7af93eb764d1fb90ec9311707784a,
title = "On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors",
abstract = "Aldose reductase (AKR1B1; ALR2; E.C. 1.1.1.21) is an NADPH-dependent carbonyl reductase which has long been associated with complications resulting from the elevated blood glucose often found in diabetics. The development of effective inhibitors has been plagued by lack of specificity which has led to side effects in clinical trials. To address this problem, a library of bead-immobilized compounds was screened against fluorescently labeled aldose reductase in the presence of fluorescently labeled aldehyde reductase, a non-target enzyme, to identify compounds which were aldose reductase specific. Picked beads were decoded via novel bifunctional bead mass spec-based techniques and kinetic analysis of the ten inhibitors which were identified using this protocol yielded IC50 values in the micromolar range. Most importantly, all of these compounds showed a preference for aldose reductase with selectivities as high as ∼7500-fold. The most potent of these exhibited uncompetitive inhibition versus the carbonyl-containing substrate d/l-glyceraldehyde with a Ki of 1.16 μM.",
keywords = "Aldose reductase, Diabetes, Inhibitors, Selective on-bead assay",
author = "Robins, {Lori I.} and Dixon, {Seth M.} and Wilson, {David K.} and Kurth, {Mark J.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/j.bmc.2006.08.005",
language = "English (US)",
volume = "14",
pages = "7728--7735",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "23",

}

TY - JOUR

T1 - On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors

AU - Robins, Lori I.

AU - Dixon, Seth M.

AU - Wilson, David K.

AU - Kurth, Mark J.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Aldose reductase (AKR1B1; ALR2; E.C. 1.1.1.21) is an NADPH-dependent carbonyl reductase which has long been associated with complications resulting from the elevated blood glucose often found in diabetics. The development of effective inhibitors has been plagued by lack of specificity which has led to side effects in clinical trials. To address this problem, a library of bead-immobilized compounds was screened against fluorescently labeled aldose reductase in the presence of fluorescently labeled aldehyde reductase, a non-target enzyme, to identify compounds which were aldose reductase specific. Picked beads were decoded via novel bifunctional bead mass spec-based techniques and kinetic analysis of the ten inhibitors which were identified using this protocol yielded IC50 values in the micromolar range. Most importantly, all of these compounds showed a preference for aldose reductase with selectivities as high as ∼7500-fold. The most potent of these exhibited uncompetitive inhibition versus the carbonyl-containing substrate d/l-glyceraldehyde with a Ki of 1.16 μM.

AB - Aldose reductase (AKR1B1; ALR2; E.C. 1.1.1.21) is an NADPH-dependent carbonyl reductase which has long been associated with complications resulting from the elevated blood glucose often found in diabetics. The development of effective inhibitors has been plagued by lack of specificity which has led to side effects in clinical trials. To address this problem, a library of bead-immobilized compounds was screened against fluorescently labeled aldose reductase in the presence of fluorescently labeled aldehyde reductase, a non-target enzyme, to identify compounds which were aldose reductase specific. Picked beads were decoded via novel bifunctional bead mass spec-based techniques and kinetic analysis of the ten inhibitors which were identified using this protocol yielded IC50 values in the micromolar range. Most importantly, all of these compounds showed a preference for aldose reductase with selectivities as high as ∼7500-fold. The most potent of these exhibited uncompetitive inhibition versus the carbonyl-containing substrate d/l-glyceraldehyde with a Ki of 1.16 μM.

KW - Aldose reductase

KW - Diabetes

KW - Inhibitors

KW - Selective on-bead assay

UR - http://www.scopus.com/inward/record.url?scp=33750038876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750038876&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2006.08.005

DO - 10.1016/j.bmc.2006.08.005

M3 - Article

VL - 14

SP - 7728

EP - 7735

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 23

ER -